Genes may determine aspirin's effect on advanced colon cancer

October 24, 2012 by Steven Reinberg, Healthday Reporter
Genes may determine aspirin's effect on advanced colon cancer
Study finds taking it appears to slow tumor growth in patients with a particular genetic mutation.

(HealthDay)—For patients suffering from advanced colorectal cancer, aspirin may prolong their lives if their tumor has a certain gene mutation, a new study finds.

"Aspirin appears to work to increase survival of colorectal patients if the tumor has PIK3CA mutation, but does not work if the tumor does not have PIK3CA mutation," said lead researcher Dr. Shuji Ogino, an associate professor in the department of epidemiology at the Harvard School of Public Health.

About 20 percent of have PIK3CA mutations, according to the study.

"PIK3CA can be potentially tested as a predictive for colorectal ," Ogino said.

"Doctors may be able to make a decision to treat or not to treat with aspirin, based on a PIK3CA test result," he added. "So a PIK3CA test can potentially make a difference to patients."

Ogino cautioned, however, that the findings need to be confirmed.

"An independent validation study is needed before PIK3CA testing can be a part of routine clinical work-up," he said.

For the study, which was published in the Oct. 25 issue of the , Ogino's team collected data on more than 900 patients with colorectal cancer who were part of the Nurses' Health Study and the Health Professionals Follow-up Study.

The data included their use of aspirin, and whether they had the PIK3CA .

The researchers found that 97 percent of the patients with the mutation who were taking aspirin were alive five years after being diagnosed, compared with 74 percent of similar patients who weren't taking aspirin.

Aspirin, however, had no effect on prolonging life among patients who didn't have the PIK3CA gene mutation, the study showed.

Earlier research suggested aspirin could block an enzyme that slows in patients with this particular gene mutation, Ogino said, which is why they decided to do the study.

The optimal aspirin dose is unknown, Ogino said. "Baby aspirin may work, but we need more studies about dose," he noted.

Dr. Boris Pasche, director of hematology/oncology at the University of Alabama at Birmingham, said, "While several new drugs have demonstrated efficacy in metastatic colorectal cancer in the past decade, only one of them (oxaliplatin) has proven useful in warding off tumor recurrence in patients with locally advanced disease.

Aspirin has benefits in preventing colorectal cancer, but its role in the treatment of established colorectal cancer is yet to be defined, he said.

"If validated in additional studies, aspirin could become a new drug to be added to the regimen, which is currently the worldwide standard of care for patients with stage III colorectal cancer," Pasche said. "It would significantly improve the outcome of patients with stage III colorectal cancer that carry mutations of the PIK3CA gene."

For Pasche, who wrote an accompanying journal editorial, the bottom line is, "an old drug may become a 21st century targeted therapy ushering [in] a tangible personalized medicine application in colorectal cancer."

Although the researchers found an association between taking and longer life among colorectal cancer patients, a cause-and-effect relationship was not proven.

Explore further: Should aspirin be used to prevent cancer?

More information: For more information on colon cancer, visit the American Cancer Society.

Related Stories

Should aspirin be used to prevent cancer?

October 1, 2012
Aspirin, the everyday drug taken by countless people around the world to ward off pain and reduce their risk of developing heart disease, may have a new trick up its sleeve –-preventing cancer.

New class of cancer drugs could work in colon cancers with genetic mutation, study finds

April 25, 2011
A class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations could potentially benefit colorectal cancer patients with a different genetic mutation, a new study from the University of Michigan ...

Recommended for you

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Dietary fat, changes in fat metabolism may promote prostate cancer metastasis

January 15, 2018
Prostate tumors tend to be what scientists call "indolent" - so slow-growing and self-contained that many affected men die with prostate cancer, not of it. But for the percentage of men whose prostate tumors metastasize, ...

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.